OMB is approving
this information collection request for a period of six months
during which time the agency will request approval to extend or
revise the collection if the agency seeks to continue the
information collection activity beyond the period approved under
this action. Previous terms continue. Approved with the
understanding that changes in data elements will be submitted as
nonsub changes and larger revisions, including methodology, methods
of administration, or the addition of conditions will be submitted
as revisions. CDC will work with their OIRA desk officer to brief
upcoming changes and determine the appropriate pathways for
submission.
Inventory as of this Action
Requested
Previously Approved
07/31/2020
4 Months From Approved
04/30/2022
7,948
0
7,288
20,045
0
19,578
851,619
0
830,600
The National Notifiable Diseases
Surveillance System is the nation's public health surveillance
system used to monitor the occurrence and spread of nationally
notifiable conditions. The NNDSS facilitates the submission and
aggregation of case notification data voluntarily submitted to CDC
from 60 jurisdictions including health departments in every U.S.
state, New York City, Washington DC, 5 U.S. territories, and 3
freely associated states. It is the official source of statistics
in the U.S. for nationally notifiable conditions and CDC is the
sole repository for these national, population-based data. 2019
novel coronavirus (2019-n-CoV) to the National Notifiable Diseases
Surveillance System (NNDSS). NNDSS is the nation’s public health
surveillance system used to monitor the occurrence and spread of
nationally notifiable conditions as well as some conditions under
national standardized surveillance.
Much remains unknown
about the etiology, transmissibility, and characteristics of
2019-nCoV, and as demonstrated by previous outbreaks of
SARS-associated coronavirus and Middle East Respiratory Syndrome
(MERS), novel coronaviruses provide a significant threat of
spreading among humans and causing severe illness. Early detection
and intervention remains the best way to control the spread of
novel infectious diseases, and complying with normal clearance
timelines for 2019-nCoV would delay effective detection and control
efforts, potentially threatening public health if this novel,
poorly understood virus proves to be transmissible among humans,
2019 novel coronavirus (2019-n-CoV) to the National Notifiable
Diseases Surveillance System (NNDSS).
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
States - One-time SO/GI Survey
OMB Emergency Review Memo_nCov 0728_1.18.20.pdf
OMB_0920-0728_Change Request_Plague Tularemia_06212019.doc
Att 20 - Burden Table Calculations.xlsx
SSA_nCoV to NNDSS_1.22.2020 CLEAN.docx
Cities - Responses for 180 Days